Authors: Jungwirth, A Gogus, C Hauser, W Gomahr, A Schmeller, N Aulitzky, W Frick, J

Citation: A. Jungwirth et al., Clinical outcome of microsurgical varicocelectomy in infertile men, ANDROLOGIA, 33(2), 2001, pp. 71-74

Authors: Schwab, M Schaeffeler, E Marx, C Zanger, U Aulitzky, W Eichelbaum, M

Citation: M. Schwab et al., Shortcoming in the diagnosis of TPMT deficiency in a patient with Crohn's disease using phenotyping only, GASTROENTY, 121(2), 2001, pp. 500-501

Authors: Wandt, H Frank, M Denzel, T Aulitzky, W Bodenstein, H Brack, N Duerk, H Engberding, R Fauser, A Geer, T Germann, B Gramatzki, M Kaesberger, J Kisro, J Knigge, O Kochling, G Kuse, R Link, H Neubauer, A Ohl, S Pfluger, R Saal, J Schakel, U Schalk, K Schmidt, H Soucek, S Wagner, T Wilms, K Winter, R Ehninger, G

Citation: H. Wandt et al., The 10.000/mu l morning trigger for prophylactic platelet transfusion is safe: Prospective experience in 411 AML patients, HEMAT BLOOD, 40, 2001, pp. 488-490

Authors: Fritz, P Seizer-Schmidt, R Murdter, TE Kroemer, HK Aulitzky, W Andre, S Gabius, HJ Friedel, G Toomes, H Siegle, I

Citation: P. Fritz et al., Ligands for Viscum album agglutinin and galectin-1 in human lung cancer: Is there any prognostic relevance?, ACT HISTOCH, 101(3), 1999, pp. 239-253

Authors: Lindauer, M Domkin, D Dohner, H Kolb, HJ Neubauer, A Huhn, D Kreiter, H Koch, B Huber, C Aulitzky, W Fischer, T

Citation: M. Lindauer et al., Efficacy and toxicity of IFN-alpha 2b combined with cytarabine in chronic myelogenous leukaemia, BR J HAEM, 106(4), 1999, pp. 1013-1019

Authors: Schneller, F Schuler, M Schumacher, K Thaler, J Peschel, C Huber, C Aulitzky, W

Citation: F. Schneller et al., Idarubicin and intermediate-dose cytarabine for myeloid blast crisis of chronic myelogenous leukemia - results of a phase-II trial, ANN HEMATOL, 77(5), 1998, pp. 225-229